Medicines in Development for Immuno-Oncology 2017 Report

PhRMA June 1, 2017

To download the full report, click here.

More than 240 immuno-oncology treatments in development are accelerating progress for patients with cancer. The rapid pace of scientific advances has helped usher in a new era of medicine for cancer patients over the last decade. Biopharmaceutical researchers’ understanding of the underlying biological mechanisms that initiate and control cancer cell growth have created promising new avenues for treatment advances. Research into the role of the body’s immune system in fighting cancer has yielded some of the most exciting new advances, resulting in a new wave of immunotherapies specifically targeting cancers.

Download Full Report